Mushrooms for patient use are shown at a psilocybin service center in Gresham, Ore., Monday, Nov. 18, 2024. (AP Photo/Craig Mitchelldyer) Buy Photo The Gazette offers audio versions of articles using ...
As he began the brain scan, neurologist Dr. Nico Dosenbach wasn’t sure if he’d been given a psychedelic or a placebo as part of a new clinical trial that would capture how the brain works on ...
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy ...
The healing power of psychedelics — especially magic mushrooms — has been studied for decades. More recently, the U.S. Food and Drug Administration has heralded it as a breakthrough treatment for ...
The matchup: Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant escitalopram, often sold as Lexapro or Cipralex. Escitalopram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback